Search

everythinglearnresearchcommunity

for

Search:↓

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Certain amino acid analogues can inhibit wool and hair growth and affect fiber strength.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Chemotherapy reduces splenic melanin in mice.

Platinum-based chemotherapy drugs can cause many severe side effects, often requiring dose reductions and additional medications to manage.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Topical alpha-terthienyl with UVA may safely treat psoriasis without cancer risk.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Phenylpropanoid sucrose esters show potential as anticancer agents.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Docetaxel is effective against various cancers but mainly causes neutropenia.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

High-dose methotrexate can cause severe skin and nail issues.

Aminopterin strongly suppresses epithelial tissues and can treat certain skin conditions but has significant side effects.

The drug combination was safe and showed promise in treating advanced tumors.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.